Engineering a Membrane-Anchored CreER Recombinase With Reduced Basal Activity for In Vitro Recombination

  • Biotechnol J. 2026 May;21(5):e70236. doi: 10.1002/biot.70236.
Xiaotong Zeng  1 Xinyi Chen  1 Zishan Liang  1 Zhanze Yang  1 Junwei Li  1 Zhengrong Zhou  2 Chiju Wei  1  3 Aihua Mao  1  3
Affiliations
  • 1. Department of Biology, Shantou University, Shantou, Guangdong, China.
  • 2. Neuroscience center, Department of Basic Medical Sciences, Shantou University Medical College, Shantou, Guangdong, China.
  • 3. Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong, China.
Abstract

The CreER-loxP system is widely utilized for genetic cell lineage tracing and conditional gene function analysis. However, issues have arisen concerning the unintended labeling of nontarget cell populations, which complicate experimental data analysis and interpretation. In this study, we constructed an engineered CreER-loxP system in which a membrane‑localization motif was fused to the C‑terminus of Cre, thereby anchoring the fusion protein to the cell membrane and minimizing its spontaneous leakage into the nucleus. This membrane‑tethered CreER-loxP (mCreER-loxP) system substantially reduced nonspecific labeling in the absence of tamoxifen. Upon tamoxifen induction, the membrane‑localized Cre dissociated from the membrane and translocated into the nucleus, maintaining comparable recombination efficiency with the conventional CreER-loxP system. Notably, the membrane‑tethering design demonstrates enhanced performance under conditions of high expression levels and extended duration in vitro, even within the more stringent ERCreER-loxP labeling framework. Furthermore, mCreER exhibited reduced cytotoxicity relative to standard CreER. Collectively, these results indicate that the mCreER-loxP system provides improved temporal and spatial precision for applications in cell lineage tracing and genetic engineering.

Keywords
Cre‐loxP system; cell labeling; membrane tethering; tamoxifen‐independent recombination.
Products